|
[1]
|
Bagshaw, S.W. and Gibney, R.T. (2008) Conventional markers of kidney function. Crit Care Med, 36, S152-S158.
|
|
[2]
|
陆再英, 钟南山, 主编 (2008) 内科学. 北京人民卫生出版社, 北京, 51-262.
|
|
[3]
|
Mule, G., Cottone, S., Nardi, E., et a1. (2006) Metabolic syndrome in subjects with essential hypertension: Relationships with subclinical cardiovascular and renal damage. Minerva Car- dioangiologica, 54, 173-194.
|
|
[4]
|
Talaat, K.M. and EI-Sheikh, A.R. (2007) The effect of mild hyperuricemia on urinary transforming growth factor beta and the progression of chronic kidney disease. American Journal of Nephrology, 27, 435-440.
|
|
[5]
|
Convento, M.S., Pesson, E., Dalboni, M.A., et al. (2011) pro- inflammatory and oxidative effect of noncrystalline uric acid in human mesangial cells: Contribution to hyperuricemic glomerular damage. Urological Research, 39, 21-27.
|
|
[6]
|
Qian, Q., Kassem, K.M., Beierwaltes, W.H., et al. (2009) PGE2 causes mesangial cell hypertrophy and decreases expression of cyclin D3. Nephron Physiology, 113, 7-14.
|
|
[7]
|
Luc, G., Bard, J.M. and Lesueur, C. (2006) Plasma cystatin-C and development of Coro-nary heart disease: The PRIME Study. Atherosclerosis, 18, 375-380.
|
|
[8]
|
Bokenkamp, A., Herget-Rosenthal, S., Bokenkamp, R. and Cystatin, C. (2006) kidney function and cardiovascular rdisease. Pediatric Nephrology, 21, 1223-1230.
|
|
[9]
|
Madero, M., Sarnak, M.J. and Stevens, L.A. (2006) Serum cystatin C as a marker of glomerular filtrationrate. Current Opinion in Nephrology and Hypertension, 15, 610-616.
|